| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| SOLESENCE Aktie jetzt für 0€ handeln | |||||
| 11.09. | Solésence Beauty Science win the inaugural Cosmetics Business Innovation Awards for Contract Manufacturing Partner of the Year | 13 | Cosmetics Business | ||
| 20.08. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Solesence Reports Q2 2026 Results: Full Earnings Call Transcript | 4 | Benzinga.com | ||
| 19.08. | Solesence reports Q2 results | 1 | Seeking Alpha | ||
| 19.08. | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | 548 | GlobeNewswire (Europe) | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| 19.08. | SOLESENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.07. | Solésence, Inc.: Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp | 4 | GlobeNewswire (USA) | ||
| 10.07. | SOLESENCE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.06. | Solésence, Inc.: Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards | 7 | GlobeNewswire (USA) | ||
| 19.05. | Solésence, Inc.: Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Alle Awards, Marking Fourth Year of Recognition | 3 | GlobeNewswire (USA) | ||
| 15.05. | Solésence, Inc.: Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition | 2 | GlobeNewswire (USA) | ||
| 12.05. | SOLESENCE, INC. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 12.05. | Solesence targets 30% gross margin floor while aiming to return to double-digit EBITDA margins by year-end 2026 | 2 | Seeking Alpha | ||
| 12.05. | Solesence GAAP EPS of -$0.01, revenue of $13M | 2 | Seeking Alpha | ||
| 12.05. | Solesence: Umsatzrückgang und Ergebnisverlust in Q1 2026 belasten Aktie | 4 | Investing.com Deutsch | ||
| 12.05. | Solesence Reports Q1 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 12.05. | SOLESENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.05. | Solésence, Inc.: Solésence Launches New Skin Health Technologies: WHSPR and Chromalüm | 8 | GlobeNewswire (USA) | ||
| 29.04. | SOLESENCE, INC. - 8-K, Current Report | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,120 | -0,73 % | Formycon und die Patentklippe: Warum auslaufende Patente bei Novartis oder Merck für das deutsche Biotech eine Chance sind | Selbst die Großen der Pharmabranche kommen unter Druck. Das Stichwort in diesem Zusammenhang: Patentklippe. Zwischen 2025 und 2030 verlieren laut Branchenschätzungen Wirkstoffe mit einem globalen Umsatzvolumen... ► Artikel lesen | |
| RIBER | 8,050 | 0,00 % | Riber Reports Improved Results For The First Half Of 2026 | RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| GAUZY | 4,980 | 0,00 % | GAUZY LTD: Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal | TEL AVIV, Israel, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced receipt of a delisting... ► Artikel lesen | |
| ONTO INNOVATION | 265,30 | +1,65 % | Analysten-Upgrade und Konjunkturdaten beflügeln Onto Innovation-Aktie | ||
| VEECO INSTRUMENTS | 46,050 | +0,30 % | Why Veeco Instruments Stock Crushed it Last Month | ||
| NANOFORM FINLAND | 0,804 | +6,77 % | Nanoform Finland Oyj: Nanoform Q2 2026 - Positive feedback from scientific advice meeting in the UK, significantly improved cash flow and discussions with CDMOs on sterile GMP for our Biologics technology initiated | Nanoform Finland Plc | Company Release | August 20, 2026 at 08:10:00 EEST
Nanoenzalutamide project continues with the communicated multitrack strategy supported by all partners. After a positive scientific... ► Artikel lesen | |
| GOMSPACE | 0,901 | +3,57 % | GomSpace Launches GOMX-5 to Demo Next-Gen Satellite Communications Technologies | ||
| NVE | 101,00 | +1,51 % | Dividendenbekanntmachungen (03.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR BF SPA IT0005187460 - 0,038 EUR CITIZENS & NORTHERN CORPORATION US1729221069 0... ► Artikel lesen | |
| NANOVIRICIDES | 1,190 | +0,85 % | NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026 | SHELTON, CT / ACCESS Newswire / October 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("the Company") is pleased to announce that it will be presenting tomorrow October 7, 2026 at NIBA's 153rd... ► Artikel lesen | |
| DOTZ NANO | 0,014 | 0,00 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| KOPIN | 3,904 | 0,00 % | Stifel bestätigt Kaufempfehlung für Kopin nach neuem Rüstungsauftrag | ||
| OBDUCAT | 0,030 | -6,25 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| ACACIA RESEARCH | 3,820 | 0,00 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
| ADVANCE ZINCTEK | 0,346 | 0,00 % | ADVANCE ZINCTEK LIMITED: First Quarter FY27 Australian Revenue Down 71% | ||
| LAMPETIA | 0,156 | 0,00 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen |